Secondary Logo

Institutional members access full text with Ovid®

Personalized Pancreatic Cancer Management

A Systematic Review of How Machine Learning Is Supporting Decision-making

Bradley, Alison, MRCSEd*†; van der Meer, Robert, PhD*; McKay, Colin, FRCS

doi: 10.1097/MPA.0000000000001312
Reviews
Buy
SDC

This review critically analyzes how machine learning is being used to support clinical decision-making in the management of potentially resectable pancreatic cancer. Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines, electronic searches of MEDLINE, Embase, PubMed, and Cochrane Database were undertaken. Studies were assessed using the checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS) checklist. In total 89,959 citations were retrieved. Six studies met the inclusion criteria. Three studies were Markov decision-analysis models comparing neoadjuvant therapy versus upfront surgery. Three studies predicted survival time using Bayesian modeling (n = 1) and artificial neural network (n = 1), and one study explored machine learning algorithms including Bayesian network, decision trees, k-nearest neighbor, and artificial neural networks. The main methodological issues identified were limited data sources, which limits generalizability and potentiates bias; lack of external validation; and the need for transparency in methods of internal validation, consecutive sampling, and selection of candidate predictors. The future direction of research relies on expanding our view of the multidisciplinary team to include professionals from computing and data science with algorithms developed in conjunction with clinicians and viewed as aids, not replacement, to traditional clinical decision-making.

From the *Department of Management Science, University of Strathclyde Business School; and

West of Scotland Pancreatic Cancer Unit, Glasgow Royal Infirmary, Glasgow, Scotland.

Received for publication October 22, 2018; accepted March 25, 2019.

Address correspondence to: Alison Bradley, MRCSEd, University of Strathclyde Business School, Duncan Wing 606, 199 Cathedral Street, Glasgow, G4 0QU, United Kingdom (e-mail: bradley_alison@live.co.uk).

The authors declare no conflict of interest.

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.pancreasjournal.com).

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.